The Liver Meeting 2019-Managing HCV Cirrhotic Patients After Achieving SVR: Who Will Progress to Developing Hepatocellular Carcinoma?*

Managing HCV Cirrhotic Patients After Achieving SVR: Who Will Progress to Developing Hepatocellular Carcinoma?*

Video Transcription

Video Summary

The speaker discussed a case of a 59-year-old woman with cirrhosis due to hepatitis C virus infection, who achieved sustained virological response after treatment. They emphasized the importance of surveillance for hepatocellular cancer (HCC) in patients with cirrhosis, even post-treatment. Factors impacting HCC risk, such as fibrosis and epigenetic changes, were highlighted. Various tools, including fibrosis scoring and liver stiffness measurements, were discussed for predicting HCC risk. Lifestyle factors like diet, physical activity, and medications like metformin and statins were suggested to reduce HCC risk. The importance of personalized risk assessment and surveillance strategies tailored to individual risk levels was underscored. The talk stressed the need for ongoing efforts in monitoring and addressing risk factors to mitigate the development of HCC in at-risk patients.

Asset Caption

Presenter: Tushar Patel

Keywords

cirrhosis

hepatitis C virus

sustained virological response

hepatocellular cancer

fibrosis scoring

liver stiffness measurements